Jason Halford
Prof Jason Halford is the former president of the European Association for the Study of Obesity and serves as the head of psychology at Leeds University. His expertise lies in the intersection of obesity and health outcomes, particularly in cancer care. In light of recent research showing the potential of weight-loss drugs to significantly reduce cancer risk, he expressed optimism about their role not only in prevention but also in improving outcomes for patients recently diagnosed with cancer.
Not in the pool (under ¢1).
Recent news mentions
Jason Halford of the European Association for the Study of Obesity explains how GLP-1s can change relationships with food.
How do weight loss medications affect our relationship with food?
Taiwan· 2025-09-23
Jason Halford, head of the Psychology Department at the University of Leeds, suggests that the drugs should also be tested on newly diagnosed patients to determine if they increase survival chances.
Index - Tudomány - Áttörés jöhet a rákmegelőzésben, ez jelentheti a megoldás kulcsát
Hungary· 2025-05-16
Jason Halford is associated with the European Association for the Study of Obesity.
People who stop weight loss drugs return to original weight within year, analysis finds | Health
United Kingdom· 2025-05-14
Prof Jason Halford is the former president of the European Association for the Study of Obesity and head of psychology at Leeds University.
Weight-loss jabs could halve risk of obesity-related cancers, study finds | ObesityUnited Kingdom· 2025-05-12